文献速递类风湿关节炎脊柱关节炎

显著减重对疾病活动度的影响:在临床实践中实施非药物干预的理由

Effect of significant weight loss on disease activity: reason to implement this non-pharmaceutical intervention in daily clinical practice.
PubMed 文献 · RMD Open · 2021-01-01

该病例系列显示,在类风湿关节炎或银屑病关节炎患者中,体重下降超过10%可使DAS28中位数降低0.9,缓解率从6%升至63%,且87%的患者未强化药物治疗。结果支持减重作为肥胖炎症性风湿病患者的一种非药物治疗选择。

要点

  • 肥胖在炎症性风湿病患者中常见,27%至37%的患者BMI≥30 kg/m2。
  • 体重下降超过10%与DAS28中位数降低0.9及缓解率从6%升至63%相关。
  • 87%的患者在未强化药物治疗的情况下获得疾病活动度降低。

核心结论

  • 减重对肥胖炎症性风湿病患者的疾病病程有积极影响,并可改善其心血管疾病风险谱。
  • 减重可作为肥胖炎症性风湿病患者的一种非药物治疗选择。

研究设计与样本

  • 该研究为病例系列,纳入类风湿关节炎或银屑病关节炎患者。
  • 原文未报告样本量、随访时间及具体统计方法。

主要发现

  • 在体重下降超过体重10%的患者中,DAS28中位数降低0.9。
  • 疾病活动度降低使达到缓解的患者比例从6%升至63%。
  • 87%的患者在未强化药物治疗的情况下获得疾病活动度降低。

关键数值与推荐

  • 肥胖定义为体重指数≥30 kg/m2,炎症性风湿病患者中27%至37%符合此标准。
  • 显著减重定义为体重下降超过体重的10%。

临床怎么用

  • 对肥胖的炎症性风湿病患者,可考虑将减重作为非药物干预措施纳入日常临床实践。
  • 减重可能在不强化药物治疗的情况下降低疾病活动度并提高缓解率。

局限性

  • 原文未报告研究设计细节、样本量、随访时间及混杂因素控制情况。
  • 作为病例系列,证据等级有限,需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obesity is very common in patients with inflammatory rheumatic diseases (IRDs), of which between 27% and 37% of patients have a body mass index ≥30 kg/m2 In addition to further increasing the risk of developing cardiovascular diseases (CVDs) in this group of patients, obesity is associated with higher disease activity and a lower response to drug therapy. This case series showed that in those patients with rheumatoid arthritis or psoriatic arthritis with a substantial weight loss of >10% of body mass, median Disease Activity Score 28 joints score decreased with 0.9. This reduction in disease activity resulted in an increase in the percentage of patients achieving remission from 6% to 63%. This reduction in disease activity was obtained without intensification of medical treatment in 87% of the patients. This case series supports the current evidence that weight reduction has positive effects on the course of the disease and thus also on the CVD risk profile in these patients. Therefore, weight loss can serve as a non-pharmacological treatment option in obese patients with IRDs.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Weijers JM, Müskens WD, van Riel PLCM, et al. Effect of significant weight loss on disease activity: reason to implement this non-pharmaceutical intervention in daily clinical practice. RMD Open. 2021. PMID: 33504577. doi:10.1136/rmdopen-2020-001498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。